Memorial Sloan Kettering Nassau (Limited Protocol Activity) is a clinical research site located in Uniondale, New York, United States 11553.
Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.
Memorial Sloan Kettering Nassau (Limited Protocol Activity) has participated in 1 clinical trials with 1 currently active.
Therapeutic areas: BRCA1 Mutation, POLD1 Gene Mutation, CDKN2A Mutation.
Sponsors: Memorial Sloan Kettering Cancer Center.
Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Memorial Sloan Kettering Nassau (Limited Protocol Activity) has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Memorial Sloan Kettering Nassau (Limited Protocol Activity) has 1 clinical trials on record, with 1 currently active. Their work covers BRCA1 Mutation, POLD1 Gene Mutation, CDKN2A Mutation.
Memorial Sloan Kettering Nassau (Limited Protocol Activity) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.